CD274 and Miyoshi myopathy: The role of PD-1/PD-L1 pathway in mediating immune escape of malignant PCs and the therapeutic efficacy of PD-1/PD-L1 blockade in other hematological malignancies led to an increased interest in the use of anti-PD-1/PD-L1 therapeutic strategies in MM (68).